Sort   by:  
 Page size 
ProteomicsProteome alteration in Myeloma, MGUS to MM transition
We have measured the proteomic changes on ANBL6, IH1, INA6, U266, KJON, OH2, VOLIN, LR5, KARPAS, RAMOS cell lines and used it to build a super SILAC library in order to quantify proteomic changes from MGUG to MM stages of Myeloma with Elite orbitrap mass spetrometer.
ORGANISM(S): Homo sapiens (Human) 
2024-06-07 | PXD006458 | Pride
Lr5 Oribitrap Volin Anbl6 Myeloma Oh2 U266 Silac Kjon Karpas Ih1 Super Ina6 Ramos 
GenomicsHeterogeneous expression of cell surface markers in human myeloma cell lines: implications for disease modelling and therapeutic targeting
Heterogeneous expression of cell surface markers in human myeloma cell lines: implications for disease modelling and therapeutic targeting
PRJNA1052711 | ENA
ProteomicsProteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia
Plasma cell leukemia is a rare and aggressive plasma cell neoplasm that may either originate de novo (primary PCL) or by leukemic transformation of multiple myeloma (MM) to secondary PCL (sPCL). The prognosis of sPCL is very poor, and currently no standard treatment is available due to lack of prosp...
ORGANISM(S): Homo sapiens (Human) 
2017-05-02 | PXD001963 | Pride
Mm Cell Leukemia Secondary Plasma Pcl Myeloma 
ProteomicsBiomarker discovery and subtype classification within Multiple Myeloma by Super-SILAC
Multiple Myeloma (MM) is the second most prevalent blood cancer (10%) after non-Hodgkin's lymphoma and represents approximately 1% of all cancers and 2% of all cancer deaths. MM is a complex disease characterized by numerous genetic alterations and recent mRNA profiling studies have attempted to sub...
ORGANISM(S): Homo sapiens (Human) 
2024-07-15 | PXD003138 | Pride
Silac Genome Correlation Lc-msms 
Sort   by:  
 Page size